Nevro (NYSE: NVRO) is a public multinational medical technology company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform.
We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has impacted the lives of over 28,000 patients around the world.
The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States.
The Therapy Optimization Consultant (TOS) serves as the technical expert to deliver optimal patient outcomes. The TOS is the liaison between the Field Clinical Engineers and the sales teams, ensuring best practices are applied to the therapy in a standardized, consistent fashion.
Bachelor’s degree or equivalent combination of education and experience. Demonstrated ability to develop and influence relationships. Analytical skills, including statistical analysis. PC skills necessary (MS Office/Excel) and experience.